---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 121-123, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - June 2, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 14-20, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - June 2, 2017 Category: Hematology Source Type: research
Blood prime for patients with single ‐needle access requiring extracorporeal photopheresis: How to do and why it may be useful
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - June 2, 2017 Category: Hematology Authors: Michael N. Boshell, Daniel B. Peavey, Sierra C. Simmons, Lance A. Williams, Huy P. Pham Tags: LETTER TO THE EDITOR Source Type: research
What is the evidence to support the use of plasma exchange as first ‐line therapy for N‐methyl d‐aspartate receptor antibody encephalitis?
(Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - June 1, 2017 Category: Hematology Authors: Eric A. Gehrie, Emily A. Coberly, Angela Treml, Christopher Tormey, Garrett S. Booth Tags: LETTER TO THE EDITOR Source Type: research
A liquid calcium+vitamin D3 supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation
We examined whether repeated prophylactic doses of calcium carbonate, or of a liquid preparation containing calcium citrate, calcium phosphate, and vitamin D3, would be more effective at preventing symptoms of hypocalcemic toxicity. Symptoms were reported by 48% of donors who received no prophylaxis and 60% of donors who received 1000 mg of oral calcium carbonate at the start of, and every 20 minutes during, donation (P = 0.711). Only 19.2% of donors who received the liquid preparation (1000 mg calcium, 1000 IU vitamin D3) reported symptoms (P = 0.040 versus no prophylaxis, P = 0.039 versus calcium carbonate). This differe...
Source: Journal of Clinical Apheresis - June 1, 2017 Category: Hematology Authors: Robert Weinstein, Stefanie Haynes, Yong Zhao, Elda Hickson, Jeanne Linden, Patricia St. Pierre, Paula Ducharme, Paula Sulmasy, Molly Graves, Jeffrey A. Bailey, Linda Welch, Amie Simard, Michelle Vauthrin, Mindy Greene Tags: RESEARCH ARTICLE Source Type: research
UK consensus statement on the use of plerixafor to facilitate autologous Peripheral Blood Stem Cell collection to support high ‐dose chemoradiotherapy for patients with malignancy
Plerixafor is a CXC chemokine receptor (CXCR4) antagonist that mobilizes stem cells in the peripheral blood. It is indicated (in combination with granulocyte‐colony stimulating factor [G‐CSF]) to enhance the harvest of adequate quantities of cluster differentiation (CD) 34+ cells for autologous transplantation in patients with lymphoma or multiple myeloma whose cells mobilize poorly. Strategies for use include delayed re‐mobilization after a failed mobilization attempt with G‐CSF, and rescue or pre‐emptive mobilization in patients in whom mobilization with G‐CSF is likely to fail. Pre‐emptive use has the adva...
Source: Journal of Clinical Apheresis - June 1, 2017 Category: Hematology Authors: Kenneth W. Douglas, Maria Gilleece, Patrick Hayden, Hannah Hunter, Peter R. E. Johnson, Charlotte Kallmeyer, Ram K. Malladi, Shankara Paneesha, Rachel Pawson, Michael Quinn, Kavita Raj, Deborah Richardson, Stephen Robinson, Nigel Russell, John Snowden, An Tags: RESEARCH ARTICLE Source Type: research
Comparison of the CELLEX ™ and UVAR‐XTS™ closed‐system extracorporeal photopheresis devices in the treatment of chronic graft‐versus‐host disease
Extracorporeal Photopheresis (ECP) is a cellular immunotherapy frequently used for steroid‐refractory graft‐versus‐host disease (GVHD). Chronic GVHD (cGVHD), response to ECP is associated with survival benefit. The UVAR‐XTSTM system and the more recently developed CELLEXTM device (both TherakosTM) are the mainstay for ECP‐delivery in the UK and US. No comparison of treatment outcomes has been reported. We retrospectively compared cGVHD response and steroid reduction and withdrawal in patients treated exclusively over 12 months with either the XTS (n = 51) or CELLEX (n = 50). Our hypothesis was that there ...
Source: Journal of Clinical Apheresis - June 1, 2017 Category: Hematology Authors: Robert M. Whittle, Helen Denney, Andrew D. Chantry, Arun Alfred, Peter C. Taylor Tags: RESEARCH ARTICLE Source Type: research
Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis
ConclusionsIn this retrospective efficacy evaluation, cytapheresis was effective as remission induction therapy with steroid sparing effect and desirable safety profile. Further, patients with EN or PG responded favorably to cytapheresis. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - June 1, 2017 Category: Hematology Authors: Osamu Nomura, Taro Osada, Tomoyoshi Shibuya, Dai Ishikawa, Keiichi Haga, Tomohiro Kodani, Naoto Sakamoto, Tatsuo Ogihara, Ken Yamaji, Sumio Watanabe Tags: RESEARCH ARTICLE Source Type: research
Troubleshooting the collect concentration monitor alarm in therapeutic thrombocytapheresis
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 95-96, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 31, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 95-96, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 31, 2017 Category: Hematology Source Type: research
Poor peripheral blood stem cell mobilization affects long ‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 29-37, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 29, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 29-37, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 29, 2017 Category: Hematology Source Type: research
Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 108-112, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 24, 2017 Category: Hematology Source Type: research
---
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 108-112, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 24, 2017 Category: Hematology Source Type: research
Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines
Journal of Clinical Apheresis,Volume 33, Issue 1, Page 99-103, February 2018. (Source: Journal of Clinical Apheresis)
Source: Journal of Clinical Apheresis - May 9, 2017 Category: Hematology Source Type: research
